# Zhejiang Changhai Pharmaceuticals Co., Ltd. – FDA Inspection, May 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-changhai-pharmaceuticals-co-ltd/dba775ca-0325-48a9-b1c9-c20c80db9691
Source feed: FDA_Inspections

> FDA inspection 1208780 of Zhejiang Changhai Pharmaceuticals Co., Ltd., May 26, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208780
- Company Name: Zhejiang Changhai Pharmaceuticals Co., Ltd.
- Inspection Date: 2023-05-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1041740 - 2018-01-25](https://www.keypedia.com/records/fda_inspections/zhejiang-changhai-pharmaceuticals-co-ltd/d0b0c1ff-636e-4790-a7f5-7259fb688c0a)

## Related Officers

- [Vaishali J. Patel](https://www.keypedia.com/people/vaishali-j-patel/3d515b84-e0fd-4f96-914c-f7f09e2de307)

Company: https://www.keypedia.com/companies/zhejiang-changhai-pharmaceuticals-co-ltd/73afbd0e-6243-4d01-affb-bfaf87f0e3c2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c